Prognostic Relevance of Immunosuppressive CD155/TIGIT Signaling in Locally Advanced Rectal Cancer Patients With Neoadjuvant Chemoradiotherapy
Tumor CD155 may play a pivotal role in the response to neoCRT treatment through alternative immunological mechanisms and could become a novel immunotherapeutic target for LARC patients.
Authors
- Kuan-Chong Chao
- William Tzu‐Liang Chen (ORCID: https://orcid.org/0000-0002-6585-2437)
- Yuan‐Yao Tsai (ORCID: https://orcid.org/0000-0002-6703-0103)
- HUI-YU CHEN
- Tao‐Wei Ke (ORCID: https://orcid.org/0000-0001-6847-4008)
- Yan Lin (ORCID: https://orcid.org/0000-0003-2266-0854)
- TE-HONG CHEN
- Chen Huang (ORCID: https://orcid.org/0000-0002-7092-7587)
- Tsung-Wei Chen
- Kevin Chih‐Yang Huang (ORCID: https://orcid.org/0000-0002-0266-3233)
Institutions
- China Medical University (TW)
Publication Details
- Journal
- Anticancer Research
- Published
- 2024-12-30
- DOI
- https://doi.org/10.21873/anticanres.17420
- Primary Topic
- Immune Cell Function and Interaction
- Type
- article
- Field-Weighted Citation Impact
- 0.00